期刊文献+

含铋四联疗法联合双歧杆菌四联活菌片治疗Hp阳性消化性溃疡的疗效及对Hp根除率、不良反应的影响 被引量:1

Efficacy of of sputum-containing quadruple therapy combined with Bifidobacterium quadruple live bacteria tablets on Hp-positive peptic ulcer and its effect on Hp eradication rate and adverse reactions
下载PDF
导出
摘要 目的研究含铋四联疗法联合双歧杆菌四联活菌片治疗幽门螺杆菌(Hp)阳性消化性溃疡(PU)的疗效及对患者Hp根除率、不良反应的影响。方法 100例Hp阳性消化性溃疡患者,按照随机数字表法分为对照组及观察组,各50例。对照组采用含铋四联疗法治疗,观察组在对照组基础上服用双歧杆菌四联活菌片治疗,两组均治疗2个月。比较两组患者的临床疗效、Hp根除情况及不良反应发生情况。结果观察组总有效率为96.00%,高于对照组的74.00%,差异有统计学意义(P<0.05)。观察组不良反应发生率为14.00%,低于对照组的32.00%,差异具有统计学意义(P<0.05)。观察组Hp根除率为92.00%,高于对照组的70.00%,差异有统计学意义(P<0.05)。结论含铋四联疗法联合双歧杆菌四联活菌片治疗Hp阳性消化性溃疡疗效显著。 Objective To study the efficacy of sputum-containing quadruple therapy combined with Bifidobacterium quadruple live bacteria tablets on Helicobacter pylori(Hp)-positive peptic ulcer(PU)and its effect on Hp eradication rate and adverse reactions.Methods A total of 100 Hp-positive peptic ulcer patients were divided by random number table into control group and observation group,with 50 cases in each group.The control group received sputum-containing quadruple therapy,and the observation group received Bifidobacterium quadruple live bacteria tablets on the basis of the control group.Both groups were treated for 2 months.The efficacy,Hp eradication rate and incidence of adverse reactions were compared between the two groups.Results The observation group had higher total effective rate as 96.00%than 74.00%in the control group,and the difference was statistically significant(P<0.05).The observation group had lower incidence of adverse reactions as 14.00%than 32.00%in the control group,and the difference was statistically significant(P<0.05).The observation group had higher Hp eradication rate as 92.00%than 70.00%in the control group,and the difference was statistically significant(P<0.05).Conclusion Combination of sputum-containing quadruple therapy and Bifidobacterium quadruple live bacteria tablets shows excellent efficacy in treating Hp-positive peptic ulcer.
作者 邵华 SHAO Hua(Department of Internal Medicine,Anshan Tiedong District Hospital,Anshan 114001,China)
出处 《中国现代药物应用》 2018年第23期74-75,共2页 Chinese Journal of Modern Drug Application
关键词 含铋四联疗法 双歧杆菌四联活菌片 幽门螺杆菌阳性 消化性溃疡 Sputum-containing quadruple therapy Bifidobacterium quadruple live bacteria tablets Helicobacter pylori positive Peptic ulcer
  • 相关文献

参考文献6

二级参考文献89

  • 1Gyrgy Miklós Buzás.First-line eradication of Helicobacter pylori:Are the standard triple therapies obsolete? A different perspective[J].World Journal of Gastroenterology,2010,16(31):3865-3870. 被引量:26
  • 2崔梅花,杨友鹏,岳林,傅怡,乙国兴,牟方宏,杨桂彬,朱红霞,张秀丽.幽门螺杆菌血清抗体对埃索美拉唑四联疗法根除效果的影响研究[J].中国全科医学,2013,16(8):850-853. 被引量:16
  • 3成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 4Malfertheiner P,Megraud F,O'Morain CA,et al.Management of Helicobacter pylori infection the Maastricht IV/Florence Consensus Report[J].Gut,2012,61(5):646-664.
  • 5Gisbert JP,Calvet X.Review article:common misconceptions in the management of Helicobacter pylori associated gastric MALT-lymphoma[J].Aliment Pharmacol Ther,2011,34(9):1047-1062.
  • 6Correa P,Piazuelo MB.The gastric precancerous cascade[J].J Dig Dis,2012,13(1):2-9.
  • 7Matsuhisa T,Aftab H.Observation of gastric mucosa in Bangladesh,the country with the lowest incidence of gastric cancer,and Japan,the country with the highest incidence[J].Helicobacter,2012,17(5):396-401.
  • 8Lan HC,Chen TS,Li AF,et al.Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophy[J].BMC Gastroenterol,2012(12):182.
  • 9Galván-Pea S,ONeill LA.Metabolic reprograming in macrophage polarization[J].Front Immunol,2014(5):420.
  • 10Soares F,Tattoli I,Wortzman ME,et al.NLRX1does not inhibit MAVS-dependent antiviral signaling[J].Innate Immun,2013,19(4):438-448.

共引文献632

同被引文献18

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部